rs2855341
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The ENST00000262304.9(PKD1):c.1396G>A(p.Val466Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000701 in 1,426,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000262304.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.1396G>A | p.Val466Met | missense_variant | 7/46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.1396G>A | p.Val466Met | missense_variant | 7/46 | 1 | NM_001009944.3 | ENSP00000262304 | P5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.01e-7 AC: 1AN: 1426204Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 707294
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Polycystic kidney disease, adult type Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Feb 02, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with polycystic kidney disease 1 (MIM#173900). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from valine to methionine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (6 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated C-type lectin domain (UniProt). (I) 0710 - Another missense variant comparable to the one identified in this case has inconclusive previous evidence for pathogenicity. This alternative change (p.(Val466Leu)) has been reported as a VUS, and was identified in an individual with PKD who also had another splice variant in the PKD1 gene (pkdb.org, PMID: 17582161). (I) 0804 - This variant has previously been described as a variant of uncertain significance in multiple independent cases with consistent phenotype despite being absent in the general population. This variant has been reported as a VUS and as likely pathogenic, and has been described in at least five unrelated individuals with polycystic kidney disease (PKD) (ClinVar, pkdb.org, PMID: 17582161, PMID: 31740684, PMID: 26453610, PMID: 29270497). (SP) 0906 - Segregation evidence for this variant is inconclusive. This variant has been reported to segregate in a family, however there is insufficient evidence of each relative's phenotype (PMID: 26453610). (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Likely pathogenic, no assertion criteria provided | clinical testing | Immunogenetics and Transplant Biology Service, University Hospital "Città della Salute e della Scienza di Torino" | Jul 03, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+BP4+PS4_Moderate+PP1+PP4 - |
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 28, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 21, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32398770, 26453610, 31740684, 33437033, 17582161, 29270497) - |
Polycystic kidney disease Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Val466Met variant was identified in 2 of 844 proband chromosomes (frequency: 0.002) from individuals or families with ADPKD (Rosetti, 2007,Hwang, 2016). The variant was also identified in dbSNP (ID: rs2855341) as “With Likely pathogenic allele”, ClinVar (classified as likely pathogenic by Athena Diagnostics), ADPKD Mutation Database (classified as indeterminate, including a reference to the unpublished classification from Athena Diagnostics and to Rosetti, 2007).The variant was not identified in the LOVD 3.0 or PKD1-LOVD databases. The variant was not identified in the following control databases: the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The p.Val466Met variant was observed in one ADPKD individual in a study which observed a second individual with a substitution to leucine at the same residue, suggesting significance, however both changes are highly conservative and the residue is considered to be not well conserved, so both substitutions were classified as indeterminate (Rosetti, 2007). The variant has been observed in a case with an alternate molecular basis for disease (PKD1 c.12596_12600dup, p.Leu4201*). The p.Val466 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Autosomal dominant polycystic kidney disease Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research | Jan 01, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at